International HBOT Regulation: UK, EU, Australia Compared

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

The Undersea & Hyperbaric Medical Society (UHMS) lists 14 primary indications for hyperbaric oxygen therapy, including Air or Gas Embolism and Carbon Monoxide Poisoning UHMS Hyperbaric Oxygen Therapy Indications (14th Edition).
Gas embolism from breath holding can occur after an ascent of as little as one meter, highlighting the risks in diving and other scenarios.
UHMS guidelines, updated in the 14th Edition, are widely recognized, with the FDA recommending UHMS-accredited facilities for specific illnesses FDA Recommendation for UHMS-Accredited Facilities.
Intravenous injection of oxygen at 10 mL/min has been reported as well tolerated in humans, but 20 mL/min caused symptoms.

Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber. This treatment is recognized globally for specific medical conditions. The Undersea & Hyperbaric Medical Society (UHMS) serves as a key international body, establishing widely accepted indications for HBOT. Our analysis shows that the UHMS has identified 14 primary indications for this therapy, detailed comprehensively in its 14th Edition of "Hyperbaric Oxygen Therapy Indications" UHMS Hyperbaric Oxygen Therapy Indications (14th Edition). These indications form a baseline for clinical practice worldwide, influencing how HBOT is regulated and applied in various countries. For instance, the U.S. Food & Drug Administration (FDA) recommends UHMS-accredited facilities for the treatment of specific illnesses, underscoring the society's significant role in ensuring safety and efficacy. While specific regulatory frameworks for HBOT may vary across regions like the UK, EU, and Australia, the UHMS provides a foundational, evidence-based standard that practitioners and regulatory bodies often reference.

What are the Established Indications for Hyperbaric Oxygen Therapy?

The Undersea & Hyperbaric Medical Society (UHMS) has a well-defined list of conditions for which hyperbaric oxygen therapy (HBOT) is an accepted treatment. These indications serve as a critical reference for medical professionals and regulatory bodies worldwide. The UHMS 14th Edition of "Hyperbaric Oxygen Therapy Indications" outlines 14 primary conditions where HBOT is recommended.

Comprehensive List of UHMS Indications

The UHMS has meticulously compiled and regularly updates its list of approved indications for HBOT. This commitment to evidence-based practice ensures that the therapy is applied effectively and safely. The 14th Edition of their report includes a detailed examination of each condition, providing clinicians with the necessary guidance.

In our review of the UHMS 14th Edition, we identified the following primary indications:

Hyperbaric Treatment of Air or Gas Embolism
Arterial Insufficiencies, which includes Central Retinal Artery Occlusion and Selected Problem Wounds
Carbon Monoxide Poisoning
Clostridial Myonecrosis (Gas Gangrene)
The Effect of Hyperbaric Oxygen on Compromised Grafts and Flaps
The Role of Hyperbaric Oxygen for Acute Traumatic Ischemias
Decompression Sickness
Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research
Sudden Sensorineural Hearing Loss
Intracranial Abscess
Necrotizing Soft Tissue Infections
Refractory Osteomyelitis
Severe Anemia
Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns

These 14 indications are considered the standard by the UHMS. The 13th Edition of the UHMS report also detailed these indications, including Air or Gas Embolism and Carbon Monoxide Poisoning UHMS Hyperbaric Oxygen Therapy Indications (13th Edition). This consistency across editions highlights the stability and robustness of the evidence supporting these treatments.

The Importance of Standardized Indications

Having a standardized set of indications is crucial for several reasons. It helps ensure that HBOT is used appropriately, preventing its application in situations where it may not be beneficial or could even be harmful. These guidelines also aid in the development of treatment protocols, training for medical personnel, and the evaluation of treatment outcomes. For example, the detailed chapter on Carbon Monoxide Poisoning in the 14th Edition provides specific recommendations for treating this life-threatening condition. Similarly, the guidance on Refractory Osteomyelitis helps clinicians manage complex bone infections that have not responded to conventional therapies.

The UHMS, based in North Palm Beach, Florida, USA, plays a vital role in disseminating this information. Their publications are a cornerstone for hyperbaric medicine globally, influencing practices far beyond the United States. While specific national regulations for HBOT in the UK, EU, and Australia were not detailed in the provided research, the UHMS indications often serve as a benchmark for clinical excellence and safety in these regions, even if not explicitly adopted as law. This international recognition solidifies the UHMS's position as a leading authority in hyperbaric medicine.

How Does Air or Gas Embolism Necessitate HBOT?

Air or gas embolism is a serious medical emergency where gas bubbles enter the bloodstream, blocking blood flow. Hyperbaric oxygen therapy is a primary treatment for this condition because it helps to reduce the size of these gas bubbles and improve oxygen delivery to tissues. Understanding the origins and effects of gas embolism reveals why HBOT is so crucial for patient recovery.

Understanding Gas Embolism

Gas embolism can occur in two main forms: arterial gas embolism (AGE) and venous gas embolism (VGE). Arterial gas embolism is particularly dangerous because bubbles can travel to the brain, heart, or other vital organs, causing immediate and severe symptoms. Richard E. Moon, in "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism," explains, "Gas embolism occurs when gas bubbles enter arteries or veins. Arterial gas embolism (AGE) was classically described during submarine escape training, in which pulmonary barotrauma occurred during free ascent after breathing compressed gas at depth." This historical context underscores the severe risks associated with rapid pressure changes.

Pulmonary barotrauma, which can lead to gas embolism, can happen even with minor pressure changes. For instance, pulmonary barotrauma and gas embolism due to breath holding can occur after an ascent of as little as one meter UHMS Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism. This fact highlights the dangers for divers who may hold their breath during ascent, even from shallow depths. AGE has also been linked to normal ascent in divers with underlying lung conditions such as bullous disease and asthma.

Beyond diving, gas embolism can arise from various medical procedures and injuries. These include blast injuries, mechanical ventilation, penetrating chest trauma, chest tube placement, and bronchoscopy. Accidental intravenous air injection, cardiopulmonary bypass accidents, needle biopsy of the lung, hemodialysis, and central venous catheter placement or disconnection are also known causes. Even less common incidents like hydrogen peroxide irrigation or ingestion, arthroscopy, cardiopulmonary resuscitation, percutaneous hepatic puncture, and air blown into the vagina during orogenital sex or sexual intercourse after childbirth have been documented as causes. Surgical procedures where the site is under pressure, such as laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy, can also lead to air embolism. Massive VGE can occur when air passively enters surgical wounds elevated above the heart, creating a subatmospheric pressure in adjacent veins, as seen in sitting craniotomy, cesarean section, prostatectomy, spine surgery, hip replacement, liver resection, liver transplantation, and dental implant insertion.

How HBOT Addresses Gas Embolism

HBOT works by increasing the pressure around the body, which causes gas bubbles in the bloodstream to shrink. The high concentration of oxygen also helps to improve oxygen delivery to tissues that may have been deprived due to the blockage. In humans, continuous intravenous infusion of oxygen at 10 mL/min has been reported as well tolerated, while 20 mL/min caused symptoms UHMS Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism. This data points to the delicate balance of gas in the body and the potential for even small volumes to cause issues, especially when injected rapidly or into arteries.

While intravenous gas embolism (VGE) is common after compressed gas diving, it often remains asymptomatic. Normally, VGE bubbles are trapped by the pulmonary capillaries. However, large volumes of VGE can cause symptoms like cough, dyspnea, and pulmonary edema. These large volumes can overwhelm the pulmonary capillary network, allowing bubbles to enter the arterial circulation. VGE can also bypass the lungs entirely and enter the left heart directly if an atrial septal defect or patent foramen ovale is present. Small volumes of intra-arterially injected air can cause clinical deficits, while intravenous injection is often asymptomatic. Compared with constant infusions, injections of air are more likely to cause clinical abnormalities. This makes rapid diagnosis and treatment, often with HBOT, critical for patients experiencing gas embolism.

What is the Role of the UHMS in HBOT Regulation?

The Undersea & Hyperbaric Medical Society (UHMS) plays a pivotal role in establishing global standards for hyperbaric oxygen therapy (HBOT). While not a direct regulatory body in every country, its published indications and accreditation programs heavily influence clinical practice and regulatory oversight worldwide. The UHMS operates from 631 US Highway 1, Suite 307 North Palm Beach, FL 33408 USA UHMS Hyperbaric Oxygen Therapy Indications (14th Edition).

Setting the Standard for Indications

The UHMS is recognized as the authoritative source for evidence-based hyperbaric oxygen therapy indications. Their "Hyperbaric Oxygen Therapy Indications" report, currently in its 14th Edition, lists the conditions for which HBOT has demonstrated efficacy through rigorous scientific review. These guidelines are not merely suggestions; they represent a consensus of expert opinion and extensive research.

The significance of these indications extends beyond clinical recommendations. They often serve as the basis for insurance reimbursement policies, hospital protocols, and even national guidelines in various countries. For example, the U.S. Food & Drug Administration (FDA) recommends UHMS-accredited hyperbaric facilities for treating specific illnesses FDA Recommendation for UHMS-Accredited Facilities. This endorsement from a major regulatory agency highlights the trust placed in UHMS standards for patient safety and treatment effectiveness.

Accreditation and Quality Assurance

Beyond defining indications, the UHMS also operates a comprehensive Hyperbaric Facility Accreditation Program. This program ensures that hyperbaric centers meet strict safety, operational, and clinical standards. Facilities seeking accreditation must demonstrate adherence to best practices in equipment maintenance, staff training, patient care protocols, and emergency procedures.

Accreditation by the UHMS offers several benefits. It provides assurance to patients and referring physicians that a facility operates at a high level of quality. It also promotes consistency in care across different centers. While the research provided does not detail specific HBOT regulatory bodies or accreditation processes in the UK, EU, or Australia, it is reasonable to infer that UHMS standards and accreditation programs would be highly regarded and potentially influence local best practices, given their international reputation.

Influence on International Practice

The UHMS's influence is global. Medical professionals and researchers from around the world contribute to its committees and publications. This collaborative approach ensures that the indications and guidelines reflect the latest scientific understanding and clinical experience. The UHMS provides resources like an "Online Continuing Education Portal" and "Introductory 40-Hour Training Courses" to further educate practitioners.

The absence of specific regulatory details for the UK, EU, and Australia in the provided research means we cannot directly compare their HBOT regulations. However, the foundational work of the UHMS, particularly its evidence-based indications and accreditation processes, forms a widely accepted framework that likely informs, directly or indirectly, the regulatory environments in these and many other regions. The consistent updates, such as those found in the 14th Edition of its indications, ensure that this framework remains current and responsive to advancements in hyperbaric medicine.

Are There Other Conditions Treated with HBOT Beyond Embolism?

Yes, hyperbaric oxygen therapy (HBOT) is an established treatment for a range of medical conditions far beyond gas embolism. The Undersea & Hyperbaric Medical Society (UHMS) has identified 14 primary indications, covering various acute and chronic illnesses. These conditions often involve tissue damage, infection, or compromised blood flow, all of which can benefit from increased oxygen delivery under pressure.

Diverse Applications of HBOT

The UHMS 14th Edition of "Hyperbaric Oxygen Therapy Indications" provides a comprehensive list of these conditions. We find that Carbon Monoxide Poisoning is listed as indication number 3 UHMS Hyperbaric Oxygen Therapy Indications (14th Edition). This is a critical application, as HBOT can rapidly clear carbon monoxide from the bloodstream and reduce its toxic effects on the brain and heart. Similarly, Clostridial Myonecrosis, commonly known as gas gangrene, is indication number 4. This severe bacterial infection thrives in low-oxygen environments, making the oxygen-rich environment of HBOT highly effective in halting its progression and aiding recovery.

Other significant indications include conditions where blood supply or tissue viability is compromised. These include the enhancement of healing in Selected Problem Wounds, which is part of arterial insufficiencies (indication 2B), and the treatment of Compromised Grafts and Flaps (indication 5). When tissues are damaged or surgical grafts are at risk of failure due to poor circulation, HBOT can promote angiogenesis (new blood vessel formation) and improve oxygen supply, thereby increasing the chances of successful healing and graft survival. Acute Traumatic Ischemias (indication 6) also benefit from HBOT, as it helps salvage tissues threatened by reduced blood flow following injury. See the crush injury and compartment syndrome evidence atlas for the full study-by-study evidence breakdown.

Chronic and Complex Conditions

HBOT is also utilized for more chronic and complex conditions. Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) is indication number 8. Radiation therapy, while life-saving, can sometimes lead to long-term tissue damage that compromises blood flow and healing. HBOT helps to repair these damaged tissues by stimulating blood vessel growth and reducing inflammation. Refractory Osteomyelitis (indication 12), a persistent bone infection that resists conventional antibiotics and surgery, is another critical application. HBOT enhances the effectiveness of antibiotics and improves the body's natural healing mechanisms in affected bone.

Furthermore, HBOT has recognized benefits for conditions affecting sensory organs and the nervous system. Sudden Sensorineural Hearing Loss is indication number 9, where prompt HBOT can improve outcomes by increasing oxygen delivery to the inner ear. Intracranial Abscess (indication 10), a collection of pus within the brain, can also be treated with HBOT as an adjunct to antibiotics and surgery, helping to control infection in an oxygen-deprived environment. Severe Anemia (indication 13), when blood transfusions are not possible or are contraindicated, can temporarily be managed with HBOT, as the high partial pressure of oxygen dissolved in plasma can sustain life. Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns (indication 14) also shows how HBOT supports complex wound management, reducing edema and promoting healing in burn victims. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.

The Undersea & Hyperbaric Medical Society (UHMS) lists Compromised Grafts and Flaps as indication number 5 in its 13th Edition UHMS Hyperbaric Oxygen Therapy Indications (13th Edition). This shows the consistent recognition of HBOT's role in supporting surgical outcomes. The broad spectrum of these UHMS-approved indications demonstrates the versatility and significant therapeutic potential of hyperbaric oxygen therapy across various medical specialties. While the specifics of how these indications are legislated or reimbursed in the UK, EU, or Australia were not provided in the research, the UHMS list provides a globally respected framework for clinical practice.

What are the Risks Associated with Gas Embolism?

Gas embolism carries significant risks due to its potential to obstruct blood flow to vital organs. Whether it is arterial gas embolism (AGE) or venous gas embolism (VGE), the presence of gas bubbles in the circulatory system can lead to severe clinical deficits, and in some cases, be life-threatening. Understanding these risks is crucial for prevention and prompt treatment.

Causes and Consequences of Gas Embolism

Arterial gas embolism (AGE) often results from pulmonary barotrauma, which can occur during activities like compressed gas diving, especially during uncontrolled ascents or breath-holding. Richard E. Moon notes that "Pulmonary barotrauma and gas embolism due to breath holding can occur after an ascent of as little as one meter" UHMS Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism. This underscores how even minor pressure changes can trigger a serious medical event. AGE can also be attributed to normal ascent in divers who have underlying lung pathologies such as bullous disease or asthma, making them more susceptible.

Beyond diving, a wide array of medical procedures and traumatic events can lead to gas embolism. These include blast injuries, mechanical ventilation, penetrating chest trauma, and complications from chest tube placement or bronchoscopy. In clinical settings, accidental intravenous air injection, accidents during cardiopulmonary bypass, lung needle biopsies, hemodialysis, and issues with central venous catheter placement or disconnection are all documented causes. Gastrointestinal endoscopy, hydrogen peroxide irrigation or ingestion, arthroscopy, cardiopulmonary resuscitation, and percutaneous hepatic puncture have also been implicated. Even non-medical scenarios like blowing air into the vagina during orogenital sex or sexual intercourse after childbirth can result in air embolism.

Surgical procedures pose a particular risk, especially those where the surgical site is under pressure. Examples include laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy. Massive venous gas embolism (VGE) can occur when air passively enters surgical wounds that are elevated above the level of the heart, creating a subatmospheric pressure in adjacent veins. This phenomenon has been classically described in sitting craniotomy but has also been observed during cesarean sections, prostatectomies (both radical perineal and retropubic approaches), spine surgery, hip replacements, liver resections, liver transplantations, and the insertion of dental implants.

Severity and Clinical Impact

The severity of clinical deficits depends on the volume of air and its location within the circulatory system. Small volumes of air injected intra-arterially can cause significant clinical deficits. In contrast, intravenous injection of air is often asymptomatic, as the pulmonary capillaries typically filter out the bubbles. However, if the volume of venous gas embolism is large, it can overwhelm the capacity of the pulmonary capillary network, allowing bubbles to cross into the arterial circulation. Additionally, bubbles can enter the left heart directly via an atrial septal defect or a patent foramen ovale, bypassing the lungs altogether.

Experimental animals have tolerated intravenous injection of up to 0.5-1 mL/kg of air. In humans, continuous intravenous infusion of oxygen at 10 mL/min has been reported as well tolerated. However, a rate of 20 mL/min caused symptoms UHMS Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism. This data suggests that while the body can handle small, continuous infusions of gas, sudden injections of air are more likely to cause clinical abnormalities. The critical distinction lies in the rapid introduction of air, which can lead to immediate and severe consequences requiring urgent intervention, typically with hyperbaric oxygen therapy to reduce bubble size and restore blood flow. The risks associated with gas embolism are serious and necessitate a clear understanding of its causes and the immediate need for effective treatment.

How Are New HBOT Indications Accepted?

The Undersea & Hyperbaric Medical Society (UHMS) maintains a rigorous and structured process for evaluating and accepting new indications for hyperbaric oxygen therapy (HBOT). This systematic approach ensures that any new treatment recommendation is backed by robust scientific evidence and expert consensus, maintaining the credibility and safety of HBOT.

The UHMS Review Process

The UHMS 14th Edition of "Hyperbaric Oxygen Therapy Indications" includes a specific section dedicated to the "Acceptance (Addition) of New Indications for Hyperbaric Oxygen Therapy" UHMS Hyperbaric Oxygen Therapy Indications (14th Edition). This indicates a formal, transparent pathway for considering new applications of HBOT. The process typically involves several key steps, ensuring thorough vetting.

First, a proposed new indication must be supported by compelling scientific evidence. This usually means a body of research, including clinical trials, observational studies, and case reports, demonstrating the efficacy and safety of HBOT for the specific condition. The UHMS emphasizes evidence-based medicine, meaning that anecdotal evidence or preliminary findings alone are insufficient for acceptance.

Second, the Hyperbaric Oxygen Therapy Committee, a group of leading experts in hyperbaric medicine, undertakes a comprehensive review of the submitted evidence. This committee scrutinizes the research methodology, statistical analysis, and clinical outcomes. They assess whether the evidence is strong enough to warrant adding the condition to the official list of UHMS-approved indications. The committee's role is critical in maintaining the high standards of the UHMS.

Criteria for Acceptance

The UHMS evaluates proposed indications against specific criteria. These criteria typically include:

Scientific Validity: The proposed mechanism of action for HBOT must be biologically plausible.
Clinical Efficacy: There must be consistent evidence of positive clinical outcomes for patients treated with HBOT for the condition.
Safety Profile: The risks associated with HBOT for the new indication must be acceptable and outweighed by the potential benefits.
Reproducibility: The findings from research studies should be reproducible across different settings and patient populations.

The UHMS also considers the practical implications of a new indication, such as the availability of appropriate treatment protocols and the training required for practitioners. The commitment to a rigorous review process reflects the society's dedication to patient safety and effective treatment. Lindell K. Weaver MD, Chair and Editor of the Thirteenth Edition, emphasized the caution inherent in medical guidance, stating, "No responsibility is assumed by the Publisher or Editor for any injury and or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the material herein." This statement, from UHMS Hyperbaric Oxygen Therapy Indications (13th Edition), highlights the importance of independent clinical judgment and the continuous need for verification in medical practice, even with established guidelines.

International Impact of UHMS Decisions

The decisions made by the UHMS regarding new indications have a significant international impact. Their list of approved indications is widely referenced by healthcare providers, medical institutions, and even governmental health agencies globally, including implicitly influencing practices in regions like the UK, EU, and Australia. While these regions may have their own specific regulatory frameworks, the UHMS provides a respected, evidence-based foundation for what constitutes appropriate and effective HBOT. This ensures a degree of consistency in the application of HBOT, regardless of geographical location, promoting best practices and patient safety on a global scale.

Frequently Asked Questions

What are the most common uses for hyperbaric oxygen therapy?

The Undersea & Hyperbaric Medical Society (UHMS) identifies 14 primary indications for hyperbaric oxygen therapy (HBOT). Among these, common uses include treating air or gas embolism, carbon monoxide poisoning, and decompression sickness. HBOT is also used to enhance healing in selected problem wounds, compromised grafts and flaps, and for conditions like delayed radiation injuries. The UHMS 14th Edition provides a comprehensive list of these established uses.

How does hyperbaric oxygen therapy help with gas embolism?

Hyperbaric oxygen therapy helps with gas embolism by physically shrinking the gas bubbles in the bloodstream due to increased pressure. This reduction in bubble size allows blood flow to resume. Additionally, the high concentration of oxygen delivered during HBOT helps to oxygenate tissues that may have been deprived of oxygen due to the blockage. Pulmonary barotrauma and gas embolism due to breath holding can occur after an ascent of as little as one meter, making rapid HBOT crucial.

Is hyperbaric oxygen therapy regulated internationally?

While there isn't a single international regulatory body for hyperbaric oxygen therapy (HBOT), organizations like the Undersea & Hyperbaric Medical Society (UHMS) establish widely accepted indications and accreditation standards that influence practice globally. The FDA, for example, recommends UHMS-accredited facilities for specific illnesses, demonstrating the international recognition of UHMS standards. However, specific national regulations regarding HBOT may vary in countries like the UK, EU, and Australia.

What is the role of the UHMS in HBOT standards?

The Undersea & Hyperbaric Medical Society (UHMS) is a leading authority in hyperbaric medicine, publishing the authoritative list of HBOT indications in its 14th Edition. The UHMS also offers a Hyperbaric Facility Accreditation Program to ensure quality and safety standards. Their guidelines are evidence-based and influence clinical practice, insurance reimbursement, and regulatory oversight in many countries, including the USA where the FDA recommends UHMS-accredited facilities.

Can HBOT treat conditions other than diving-related injuries?

Yes, hyperbaric oxygen therapy treats many conditions beyond diving-related injuries like decompression sickness and gas embolism. The UHMS lists 14 primary indications, including carbon monoxide poisoning, severe infections like clostridial myonecrosis (gas gangrene) and necrotizing soft tissue infections. It also aids in the healing of chronic wounds, compromised grafts and flaps, and treats delayed radiation injuries. For instance, Carbon Monoxide Poisoning is listed as indication number 3 in the UHMS 14th Edition.